& u plasty for revascularization and treated diabetic patients. Circulation 1997;96(suppl II):7-10.

33. Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascu-larization: results of a large regional prospective study. J Am Coll Cardiol 2001;37: 1008-1015.

34. Detre KM, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients. A comparison of the randomized and observational components of the Bypass An-gioplasty Revascularization Investigation (BARI). Circulation 1999;99:633-640.

35. Brooks MM, Jones RH, Bach RG, et al. Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry. Circulation 2000;101:2682-2689.

36. Szczech L, Crowley EM, Holmes DR. Chronic renal insufficiency (CRI) in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 2000; 102(suppl II):555.

37. Mehran R, Dangas G, Gruberg L, et al. The detrimental impact of chronic renal insufficiency and diabetes mellitus on late prognosis after percutaneous coronary interventions. J Am Coll Cardiol 2000;35(suppl A):73A.

38. Marso SP, Ellis SG, Tuzcu M, et al. The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. J Am Coll Cardiol 1999;33:1269-1277.

39. Lewis EJ, Hunsicher LG, Gain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group (see comments) [published erratum appears in N Engl J Med 1993;330(2):152]. N Engl J Med 1993;329:1456-1462.

40. Laffel LM, McGill JB, Gans DJ. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med 1995;99:497-504.

41. Savage MP, Fischman DL, Slota P, et al. Coronary intervention in diabetic patients: improved outcome following stent implantation versus balloon angioplasty. J Am Coll Cardiol 1997;29(suppl A):188A.

42. Van Belle E, Bauters C, Hubert E, et al. Restenosis rates in diabetic patients. A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997;96:1454-1460.

43. Blankenbaker R, Ghazzal Z, Weintraub WS, et al. Clinical outcome of diabetic patients after Palmaz-Schatz stent implantation. J Am Coll Cardiol 1998;31(suppl A): 415A.

44. Dangas G, Kobayashi Y, D'Agate DJ, et al. Long-term results after multivessel stent- £ ing in diabetic patients. Circulation 2000;102(suppl II):731. 8

45. Deutsch E, Martin JL, Fischman DL, et al. The late benefit of coronary stenting in small vessels is reduced in diabetic patients. J Am Coll Cardiol 1998;31(suppl A): a

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment